PARKPark Dental Partners, Inc. Common StockHealthcare · Medical - Care Facilitiesas of 2026-09-16
Horizon

Issued 2026-09-16 at $20.35 · now $20.35 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, PARK has typically landed between $16.97 and $26.50 — a range of −16.6% to +30.2% from the issuance price $20.35.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

176 overlapping 1 month windows · 2025-12-032026-08-17 · basis climatology · forecast (batch).

The cone is anchored at the 2026-09-16 issuance close ($20.35) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where PARK has typically landed a month from the 2026-09-16 close of $20.35 — the range is history, not a prediction.

$16.97worst · -16.6%$26.5best · +30.2%
  • now $20.35 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $21.4 (+5.2%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $19.98$22.83
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $16.97$26.5
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 176 windows spanning 2025-12-03 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2026-02-25−21.9%−23.3%+0.0%
2026-06-30−17.7%−18.1%+0.0%
2026-02-24−17.1%−19.9%+4.4%
3 best
2025-12-23+49.4%−4.8%+49.4%
2025-12-03+48.8%+0.0%+56.0%
2025-12-22+43.4%−8.3%+43.4%

176 overlapping windows · 2025-12-032026-09-16 · not cherry-picked

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$23$102025-12-03: 6 insider purchases, $310K — Smith Christopher Charles, Gerlach Todd Christopher, SWENSON PETER G, Law Alan Siems …2025-12: 6 open-market purchases, $310K↑ buys↓ salesdirector Smith Christopher Charles — Purchase on 2025-12-03, filed same daydirector Gerlach Todd Christopher — Purchase on 2025-12-03, filed same daydirector SWENSON PETER G — Purchase on 2025-12-03, filed same daydirector Law Alan Siems — Purchase on 2025-12-03, filed same daydirector Bernander Christopher James — Purchase on 2025-12-03, filed same daydirector SMITH PHILIP IRVING — Purchase on 2025-12-03, filed same day
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2025-12-03Smith Christopher CharlesdirectorPurchase7,692 @ $13.00$100K+274.7% of holding+47.9%+76.5%10,492Form 4 · filed same day
2025-12-03Gerlach Todd ChristopherdirectorPurchase7,692 @ $13.00$100K+12.6% of holding+47.9%+76.5%68,847Form 4 · filed same day
2025-12-03SWENSON PETER GdirectorPurchase3,846 @ $13.00$50K+1.6% of holding+47.9%+76.5%239,058Form 4 · filed same day
2025-12-03Law Alan SiemsdirectorPurchase1,923 @ $13.00$25K+1.1% of holding+47.9%+76.5%181,041Form 4 · filed same day
2025-12-03Bernander Christopher JamesdirectorPurchase1,923 @ $13.00$25K+3.6% of holding+47.9%+76.5%55,756Form 4 · filed same day
2025-12-03SMITH PHILIP IRVINGdirectorPurchase769 @ $13.00$10K+27.5% of holding+47.9%+76.5%3,569Form 4 · filed same day

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

15 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-25Law Alan SiemsdirectorGift40180,961Form 4
2026-08-25Law Alan SiemsdirectorGift40181,001Form 4
2026-08-25Law Alan SiemsdirectorGift40180,961Form 4
2026-08-25Law Alan SiemsdirectorGift40181,001Form 4
2026-08-25Law Alan SiemsdirectorGift40180,961Form 4
2026-08-25Law Alan SiemsdirectorGift40181,001Form 4
2026-08-25Law Alan SiemsdirectorGift40180,961Form 4
2026-08-25Law Alan SiemsdirectorGift40181,001Form 4
2026-06-15Bernander Christopher JamesdirectorAward / grant11,18411,184Form 4
2026-06-15Law Alan SiemsdirectorAward / grant7,7967,796Form 4
2026-06-15Schaefer Anna MariedirectorAward / grant2,6322,632Form 4
2026-06-15Smith Christopher CharlesdirectorAward / grant2,6322,632Form 4
2026-06-15Steele Christopher EugenedirectorAward / grant5,8555,855Form 4
2026-06-15SWENSON PETER GdirectorAward / grant23,78523,785Form 4
2026-06-15SMITH PHILIP IRVINGdirectorAward / grant2,6322,632Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.